Last Posted: Dec 07, 2019
- Population based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high grade serous ovarian cancer
MedRXIV, December 2019 - Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course.
Takaya Hisamitsu et al. Gynecologic oncology 2019 Nov - Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.
Griffin Natalie E et al. Gynecologic oncology 2019 Nov - Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes.
Bogani Giorgio et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2019 Nov - Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).
Ruiz de Sabando Ainara et al. BMC cancer 2019 Nov 19(1) 1145 - Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
et al. Obstetrics and gynecology 2019 Dec 134(6) 1366-1367 - Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea.
Seo Jun Hyeong et al. Obstetrics & gynecology science 2019 Nov 62(6) 411-419 - Retesting of women who are negative for a BRCA1 and BRCA2 mutation using a 20-gene panel.
Lerner-Ellis Jordan et al. Journal of medical genetics 2019 Nov - Mainstreamed genetic testing in ovarian cancer: patient experience of the testing process.
McLeavy Laura et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2019 Nov - Prevalence of hereditary breast and ovarian cancer predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
Shao Di et al. Cancer science 2019 Nov
No hay comentarios:
Publicar un comentario